Detailansicht

Wissensnetz

Person

Martin Stanulla (1965-)

Arzt

Name	Martin Stanulla
Zeit	1965- (Lebensdaten)
Ort	Hannover (Geburtsort) Hannover (Wirkungsort) Kiel (Wirkungsort) Deutschland
Geschlecht	männlich
Akademischer Grad bzw. Titel	Prof. Dr. med.
Beruf	Arzt (charakteristischer Beruf) Hochschullehrer
Variante	M. Stanulla
Beziehung	Medizinische Hochschule Hannover Klinik für Pädiatrische Hämatologie und Onkologie Klinik für Allgemeine Pädiatrie (Kiel)
Weitere Angaben	2004-2008 Prof. für Molekulare Hämatologie an der Medizinischen Hochschule Hannover, seit 2008 Prof. für Molekuläre Pädiatrie an der Universität Kiel; seit 2013 Oberarzt an der Medizinischen Hochschule Hannover, Klinik für Pädiatrische Hämatologie und Onkologie
Datensatztyp	Person
GND-Nummer	141246693
Datensatz-ID	141246693
Beteiligt an alle anzeigen Germline variants in patients developing second malignant neoplasms after therapy for pediatric acute lymphoblastic leukemia—a case-control study In vitro characterization of organ toxicity of chemotherapy and targeted inhibitors for the therapy of childhood acute lymphoblastic leukemia using high-throughput drug screening Molecular complete remission following combination treatment of daratumumab and venetoclax in an adolescent with relapsed mixed phenotype acute leukemia Chemotherapy-related hyperbilirubinemia in pediatric acute lymphoblastic leukemia: a genome-wide association study from the AIEOP-BFM ALL study group GSK3α Regulates Temporally Dynamic Changes in Ribosomal Proteins upon Amino Acid Starvation in Cancer Cells Hypersensitivity reactions to native E. coli L-asparaginase in children with acute lymphoblastic leukemia treated in Trial ALL-BFM 2000: impact of treatment schedule and type of glucocorticoid in induction Pediatric T-ALL type-1 and type-2 relapses develop along distinct pathways of clonal evolution Detection of Cancer Mutations by Urine Liquid Biopsy as a Potential Tool in the Clinical Management of Bladder Cancer Patients Genetic Variation in ABCC4 and CFTR and Acute Pancreatitis during Treatment of Pediatric Acute Lymphoblastic Leukemia Hepatic sinusoidal obstruction syndrome and short-term application of 6-thioguanine in pediatric acute lymphoblastic leukemia Hepatic sinusoidal obstruction syndrome and short-term application of 6-thioguanine in pediatric acute lymphoblastic leukemia Implementation of RNA sequencing and array CGH in the diagnostic workflow of the AIEOP-BFM ALL 2017 trial on acute lymphoblastic leukemia Chromatin accessibility landscape of pediatric T‐lymphoblastic leukemia and human T‐cell precursors Impact of NUDT15 genetics on severe thiopurine-related hematotoxicity in patients with European ancestry Author Correction: Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia Die Bedeutung von Glucocorticoid-Vincristin Pulsen in der Erhaltungstherapie für das Therapieergebnis IKZF1-deletierter akuter lymphoblastischer Leukämien im Kindes- und Jugendalter MAP3K7 is recurrently deleted in pediatric T-lymphoblastic leukemia and affects cell proliferation independently of NF-κB Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia Lmo2 expression defines tumor cell identity during T‐cell leukemogenesis PDX models recapitulate the genetic and epigenetic landscape of pediatric T‐cell leukemia Frequent and sex-biased deletion of SLX4IP by illegitimate V(D)J-mediated recombination in childhood acute lymphoblastic leukemia Untersuchungen zum Zusammenwirken umweltbedingter Risikofaktoren mit genetischen und weiteren endogenen Faktoren bei der Entstehung von Leukämie im Kindesalter : Teilvorhaben 1; Pilotstudie: Sequenzierung und bioinformatische Auswertung ; Vorhaben 3611S70014 p-BioSPRE-an information and communication technology framework for transnational biomaterial sharing and access Acute B lymphoblastic leukaemia‐propagating cells are present at high frequency in diverse lymphoblast populations Genetic polymorphisms of the lymphotoxin alpha gene are associated with increased risk for lethal infections during induction therapy for childhood acute leukemia: a case-control study MTHFR 677 (C→T) polymorphism is not relevant for prognosis or therapy-associated toxicity in pediatric NHL: results from 484 patients of multicenter trial NHL-BFM 95 Polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and susceptibility to pediatric acute lymphoblastic leukemia in a German study population GSTP1 and MDR1 Genotypes and Central Nervous System Relapse in Childhood Acute Lymphoblastic Leukemia Tumor necrosis factor and lymphotoxin-alpha genetic polymorphisms and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia: a case-control study of patients treated with BFM therapy Untersuchungen zur Expression und Funktion des c-kit-Rezeptors und seines Liganden Stammzellfaktor (SCF) in humanen malignen Gliomzellinien

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Martin Stanulla (1965-)

Germline variants in patients developing second malignant neoplasms after therapy for pediatric acute lymphoblastic leukemia—a case-control study

In vitro characterization of organ toxicity of chemotherapy and targeted inhibitors for the therapy of childhood acute lymphoblastic leukemia using high-throughput drug screening

Molecular complete remission following combination treatment of daratumumab and venetoclax in an adolescent with relapsed mixed phenotype acute leukemia

Chemotherapy-related hyperbilirubinemia in pediatric acute lymphoblastic leukemia: a genome-wide association study from the AIEOP-BFM ALL study group

GSK3α Regulates Temporally Dynamic Changes in Ribosomal Proteins upon Amino Acid Starvation in Cancer Cells

Hypersensitivity reactions to native E. coli L-asparaginase in children with acute lymphoblastic leukemia treated in Trial ALL-BFM 2000: impact of treatment schedule and type of glucocorticoid in induction

Pediatric T-ALL type-1 and type-2 relapses develop along distinct pathways of clonal evolution

Detection of Cancer Mutations by Urine Liquid Biopsy as a Potential Tool in the Clinical Management of Bladder Cancer Patients

Genetic Variation in ABCC4 and CFTR and Acute Pancreatitis during Treatment of Pediatric Acute Lymphoblastic Leukemia

Hepatic sinusoidal obstruction syndrome and short-term application of 6-thioguanine in pediatric acute lymphoblastic leukemia

Hepatic sinusoidal obstruction syndrome and short-term application of 6-thioguanine in pediatric acute lymphoblastic leukemia

Implementation of RNA sequencing and array CGH in the diagnostic workflow of the AIEOP-BFM ALL 2017 trial on acute lymphoblastic leukemia

Chromatin accessibility landscape of pediatric T‐lymphoblastic leukemia and human T‐cell precursors

Impact of NUDT15 genetics on severe thiopurine-related hematotoxicity in patients with European ancestry

Author Correction: Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia

Die Bedeutung von Glucocorticoid-Vincristin Pulsen in der Erhaltungstherapie für das Therapieergebnis IKZF1-deletierter akuter lymphoblastischer Leukämien im Kindes- und Jugendalter

MAP3K7 is recurrently deleted in pediatric T-lymphoblastic leukemia and affects cell proliferation independently of NF-κB

Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia

Lmo2 expression defines tumor cell identity during T‐cell leukemogenesis

PDX models recapitulate the genetic and epigenetic landscape of pediatric T‐cell leukemia

Frequent and sex-biased deletion of SLX4IP by illegitimate V(D)J-mediated recombination in childhood acute lymphoblastic leukemia

Untersuchungen zum Zusammenwirken umweltbedingter Risikofaktoren mit genetischen und weiteren endogenen Faktoren bei der Entstehung von Leukämie im Kindesalter : Teilvorhaben 1; Pilotstudie: Sequenzierung und bioinformatische Auswertung ; Vorhaben 3611S70014

p-BioSPRE-an information and communication technology framework for transnational biomaterial sharing and access

Acute B lymphoblastic leukaemia‐propagating cells are present at high frequency in diverse lymphoblast populations

Genetic polymorphisms of the lymphotoxin alpha gene are associated with increased risk for lethal infections during induction therapy for childhood acute leukemia: a case-control study

MTHFR 677 (C→T) polymorphism is not relevant for prognosis or therapy-associated toxicity in pediatric NHL: results from 484 patients of multicenter trial NHL-BFM 95

Polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and susceptibility to pediatric acute lymphoblastic leukemia in a German study population

GSTP1 and MDR1 Genotypes and Central Nervous System Relapse in Childhood Acute Lymphoblastic Leukemia

Tumor necrosis factor and lymphotoxin-alpha genetic polymorphisms and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia: a case-control study of patients treated with BFM therapy

Untersuchungen zur Expression und Funktion des c-kit-Rezeptors und seines Liganden Stammzellfaktor (SCF) in humanen malignen Gliomzellinien